Survival of anti-Clostridium difficile bovine immunoglobulin concentrate in the human gastrointestinal tract

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 2, 1997, Pages 236-241

  Kelly, Ciarán P ^a,b,d   Chetham, Steven ^a   Keates, Sarah ^a,b   Bostwick, Eileen F ^c   Roush, Anne M ^c   Castagliuolo, Ignazio ^a,b   Lamont, J Thomas ^a,b   Pothoulakis, Charalabos ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GalaGen Inc   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BOVINE IMMUNOGLOBULIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; IMMUNOGLOBULIN G; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG FORMULATION; DRUG STABILITY; HUMAN; HUMAN EXPERIMENT; INTESTINE TRANSIT TIME; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; STOMACH SECRETION;

EID: 0031057477     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.2.236     Document Type: Article

References (34)

1. Allo, M., J. Silvia, R. Fekety, G. D. Rifkin, and H. Waskin. 1979. Prevention of clindamycin-induced colitis in hamsters by Clostridium sordellii antitoxin. Gastroenterology 76:351-355.
2. Barroso, L. A., S. W. Zang, C. J. Phelps, J. L. Johnson, and T. D. Wilkins. 1990. Nucleotide sequence of Clostridium difficile toxin B gene. Nucleic Acids Res. 18:4004.
3. Bartlett, J. G. 1992. Clostridium difficile-associated diarrhea and colitis, p. 612-617. In S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow (ed.), Infectious diseases. The W. B. Saunders Co., Philadelphia, Pa.
4. Borriello, S. P. 1990. The influence of the normal flora on Clostridium difficile colonisation of the gut. Ann. Med. 162:678-684.
5. 2 to pepsin and papain. Biochim. Biophys. Acta 535:125-137.
6. Corthier, G., M. C. Muller, T. D. Wilkins, D. Lyerly, and R. L'Haridon. 1991. Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A. Infect. Immun. 59:1192-1195.
7. Davidson, G. P., P. B. D. Whyte, E. Daniels, K. Franklin, H. Nunan, P. I. McCloud, A. G. Moore, and D. J. Moore. 1989. Passive immunization of children with bovine colostrum containing antibodies to human rotavirus. Lancet ii:709-712.
8. deRham, O., and H. Isliker. 1977. Proteolysis of bovine immunoglobulins. Int. Arch. Allergy Appl. Immunol. 55:61-69.
9. Dove, C. H., S. Z. Wang, S. B. Proce, C. J. Phelps, D. M. Lyerly, T. D. Wilkins, and J. L. Johnson. 1990. Molecular characterization of the Clostridium difficile toxin A gene. Infect. Immun. 58:480-488.
10. Fahey, J. L., and E. M. McKelvey. 1965. Quantitative determination of serum immunoglobulins using antibody-agar plates. J. Immunol. 94:84-90.
11. Fernie, D. S., R. O. Thomson, I. Batty, and P. D. Walker. 1983. Active and passive immunization against antibiotic associated caecitis in hamsters. Dev. Biol. Stand. 53:325-332.
12. Hilpert, H., B. Brüssow, C. Mietens, J. Sidoti, L. Lerner, and H. Werchau. 1987. Use of bovine milk concentrate containing antibody to rotavirus to treat rotavirus gastroenteritis in infants. J. Infect. Dis. 156:158-166.
13. Kelly, C. P., C. Pothoulakis, J. Orellana, and J. T. LaMont. 1992. Human colonie aspirates containing IgA antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding. Gastroenterology 102:35-40.
14. Kelly, C. P., and J. T. LaMont. 1993. Treatment of Clostridium difficile diarrhea and colitis, p. 199-212. In M. M. Wolfe (ed.), Gastrointestinal pharmacotherapy. The W. B. Saunders Co., Philadelphia, Pa.
15. Kelly, C. P., C. Pothoulakis, and J. T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
16. Kelly, C. P., S. Becker, J. K. Linevsky, M. A. Joshi, J. C. O'Keane, B. F. Dickey, J. T. LaMont, and C. Pothoulakis. 1994. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J. Clin. Invest. 93:1257-1265.
17. Kelly, C. P., C. Pothoulakis, F. Vavva, I. Castagliuolo, E. F. Bostwick, J. C. O'Keane, S. Keates, and J. T. LaMont. 1996. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins. Antimicrob. Agents Chemother. 40:373-379.
18. Kelly, C. P. 1996. Immune response to Clostridium difficile infection. Eur. J. Gastroenterol. Hepatol. 8:1048-1053.
19. Kim, P. H., J. P. Iaconis, and R. D. Rolfe. 1987. Immunization of adult hamsters against Clostridium difficile associated ileocecitis and transfer of protection to infant hamsters. Infect. Immun. 55:2984-2992.
20. Leung, D. Y., C. P. Kelly, M. Boguniewicz, C. Pothoulakis, J. T. LaMont, and A. Flores. 1991. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J. Pediatr. 118:633-637.
21. Libby, J. M., B. S. Jortner, and T. D. Wilkins. 1982. Effects of the two toxins of Clostridium difficile in antibiotic-associated cecitis in hamsters. Infect. Immun. 36:822-829.
22. Lyerly, D. M., D. E. Lockwood, S. H. Richardson, and T. D. Wilkins. 1982. Biological activities of toxins A and B of Clostridium difficile. Infect. Immun. 35:1147-1150.
23. Lyerly, D. M., H. C. Krivan, and T. D. Wilkins. 1988. Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1:1-18.
24. Lyerly, D. M., E. F. Bostwick, S. B. Binion, and T. D. Wilkins. 1991. Passive immunization of hamsters against disease caused by Clostridium difficile by use of a bovine immunoglobulin G concentrate. Infect. Immun. 59:2215-2218.
25. Nord, J., P. Ma, D. Dijohn, S. Tzipori, and C. O. Tacket. 1990. Treatment of cryptosporidial diarrhea in AIDS patients with bovine hyperimmune colostrum. AIDS 4:581-584.
26. Olsen, R. G., and S. Krakowka. 1979. Immunology and immunopathology of domestic animals. Charles E. Thomas, Publisher, Springfield, Ill.
27. Pearson, J., A. Allen, and C. Venables. 1980. Gastric mucus: isolated and polymeric structure of the undegraded glycoprotein: its breakdown by pepsin. Gastroenterology 78:709-715.
28. Physicians' Desk Reference. 1996. Physicians' desk reference. Medical Economics Data Production Co., Montvale, N.J.
29. Riegler, M., R. Sedivy, C. Pothoulakis, G. Hamilton, J. Zacheri, G. Bishof, E. Consentini, W. Feil, R. Schiessel, J. T. LaMont, and E. Wenzl. 1995. Clostridium difficile toxin B is more potent than toxin A in damaging human colonie epithelium in vitro. J. Clin. Invest. 95:2004-2011.
30. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J. Nutr. 125:1238-1244.
31. Tacket, C. O., G. Losonsky, H. Link, Y. Hoang, P. Guesry, H. Hilpert, and M. M. Levine. 1988. Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli. N. Engl. J. Med. 318: 1240-1243.
32. Tacket, C. O., S. B. Binion, E. Bostwick, G. L. Losonsky, M. J. Roy, and R. Edelman. 1992. Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. Am. J. Trop. Med. Hyg. 47:276-283.
33. Triadafilopoulos, G., C. Pothoulakis, M. O'Brien, and J. T. LaMont. 1987. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 93:273-279.
34. von Eichel-Streiber, C., R. Laufenberg-Feldmann, S. Sartingen, J. Schulze, and M. Sauerborn. 1990. Cloning of Clostridium difficile toxin B gene and demonstration of high N-terminal homology between toxin A and B. Med. Microbiol. Immunol. 179:271-279.